New TCM Formula Registration
Various
DevelopmentActive
Key Facts
About Universe Pharmaceuticals
Universe Pharmaceuticals' mission is to modernize and industrialize traditional Chinese medicine through a vertically integrated model from cultivation to finished dosage forms. Its core achievement is establishing a scalable production platform for TCM derivatives, targeting therapeutic areas such as cardiovascular and common respiratory conditions. The company's strategy is to capitalize on strong domestic policy support for TCM, focusing on consistent quality and distribution within China's vast healthcare system. As a public entity, it faces the dual challenge of navigating a competitive, fragmented market and demonstrating growth to public market investors.
View full company profileTherapeutic Areas
Other Various Drugs
| Drug | Company | Phase |
|---|---|---|
| New Generic Approvals | China SXT Pharmaceuticals | Application Submitted / BE Stage |
| New Dosage Form Development | Universe Pharmaceuticals | Development |
| Bag APIs | ChemWerth | Approved |
| Oral APIs | ChemWerth | Approved |
| Companion Diagnostics Development | Kiffik Biomedical | Pre-clinical |
| Portfolio of Complex Generics & 505(b)(2) Products | Alvogen | Approved/Commercial |
| Portfolio of 40+ products | Praxgen Pharmaceuticals | Development |
| Generic Product Pipeline | Lannett | ANDA Development |
| Drug Repositioning Service | Biovista | Service |
| Custom Control Development | Anchor Molecular | Development/Commercial |
| Portfolio from Steriscience Partnership | Armas Pharmaceuticals | ANDA Development/Filing |
| Generic Medicinal Products Development | Basic Pharma | Commercial |